NIO Inc. (NYSE:NIO) last session’s volume of 43567866 shares was higher than its average volume of 32740219 shares. The stock, after opening at $2.67, hit $2.74 through the close by scoring 8.3%.NIO Inc. (NIO) Analyst Opinion
NIO Inc. is currently rated as outperform by 12 stock analysts, with the company still having around 20.07% shares outstanding that can be sold short legally. The value of their shares went down by -35.53% last month. Over the course of a year, the stock has fallen by -56.99%. Financial analysts are becoming more bullish than ever, with the 6 analysts who cover the activities of NIO advising investors to buy. Experts on Wall Street have set a price target of $6.05 for the stock. The decision was arrived after looking at their 120.8% gain from current levels. At the moment, NIO Inc. (NIO) trading price is around -80.14% below its 52-week high.
Revenue had a distance of -55.63% from the previous quarter, with the company recording $1.52 billion in revenue.NIO Inc. (NYSE:NIO) Intraday View
The shares of NIO Inc. (NYSE:NIO) have struggled and recovered 16.6% ever since it recorded its 52 week low. During the course of 5 days, the stock price volatility has remained at 7.65%, increasing the time frame to a month, the volatility recorded was 7.96%. The price of their shares still hasn’t been successful in staying above its 20 day-moving average, staying at a distance of -11.6% and while its 50-day moving average is around -33.23%. In a look at the previous five trading session NIO stock has returned 7.45% and sank -56.5% when compared to its 200-day moving average that is $5.8909. NIO Inc. (NIO) will look to overcome its 0% fall that it witnessed in the past year.
As the normal trading session ended, the stock of Marker Therapeutics, Inc. (NASDAQ:MRKR), fetched in a $0.18 spike to $6.47. The session began with the stock price at $6.3, hitting a high of $6.52 before down again. For the week, analysts seem to be okay with their bullish with the consensus call staying at 1.8. Marker Therapeutics, Inc. The shares of the company tumbled -52.25% from its high $13.55, with their overall market value now roughly $286.36 million.Marker Therapeutics, Inc. (MRKR) Consensus Price Target
The price target for Marker Therapeutics, Inc. (NASDAQ:MRKR) is now around $12.7 a share, implying the stock has what it takes to grow by 96.29%. The recent trading session also indicated the stock needs to add 147.3% more meet analysts’ high consensus price target.
The current trading volume of the company was 304731 shares during the last session. That compares with the recent average volume of 426620 shares. By the end of the regular trading session, the price volatility over a 1-week span was 5.47 % while over a month it stood at 5.23%. The stock price of MRKR dropped to $6.2 during the day and at a certain time in 12 months it traded as low as $4.18. It has made a 54.78% recovery since its 52-week low point and has returned 16.58% year-to-date. [T3]